HB 637 ("The Vax Act") requires Maryland's Secretary of Health to issue science-based recommendations for immunizations, screenings, and preventive services using guidance from major medical organizations like the CDC and American Academy of Pediatrics. It expands pharmacists' authority to administer flu, COVID-19, and emergency vaccines to patients aged 3 and older (previously limited to 18+ for some vaccines) after completing specific training. The bill also mandates that health insurance plans cover these recommended services without cost-sharing for patients. This directly affects pharmacists, health insurers, and Maryland residents seeking preventive care, particularly children and adults needing routine vaccinations.
SB 790, the Public Health Reform Act, requires the Maryland Department of Health to organize the Maryland Medical Reserve Corps - a statewide volunteer network for emergencies like disease outbreaks or disasters. It allows county health directors to hire staff without state approval if positions are fully funded locally and to enter contracts if the state fails to respond within a set timeframe. The bill creates the Public Health Workforce Development Fund (using interest earnings and transfers from another fund) to support workforce training, and mandates health equity impact assessments for new legislation. These changes directly affect county health departments, state health agencies, and public health emergency response systems.
SB 504 prohibits businesses from selling consumer personal data to buyers who intend to use it for immigration enforcement. It defines "sensitive data" to include immigration status, racial origin, health information, and sexual orientation, requiring businesses to handle such data more carefully. The bill also mandates public record custodians to prevent unauthorized disclosure - especially for immigration enforcement - and requires message switching systems to implement access controls. These changes aim to strengthen privacy protections for Maryland residents while modifying existing data privacy laws in the state code.
HB 222 requires Maryland public schools and colleges to update policies and education programs to address opioid overdoses. It mandates schools to store naloxone, allow authorized staff and students to possess it, and provide liability protection for good-faith use during overdoses. The bill also adds naloxone's life-saving role to K-12 drug prevention curricula (starting in third grade) and requires annual parent notifications about school naloxone policies. Additionally, schools must report overdose incidents requiring naloxone use to the State Department. This affects all public K-12 schools and state-funded colleges.
This Maryland bill expands protections against noncompete and conflict of interest clauses by applying existing restrictions to employees of companies that move their majority of workers or headquarters out of the state. The law makes such restrictive clauses automatically unenforceable for workers earning at or below 150% of the state minimum wage, those in licensed health occupations, and direct patient care roles earning up to $350,000 annually. For higher-paid health care workers, the bill maintains current limits by capping noncompete agreements to one year and restricting geographic restrictions to within 10 miles of their primary workplace. Employers of these health care employees must also notify patients if a former employee relocates to a new practice location. The changes apply only to employment contracts signed on or after October 1, 2026.
HB 813 authorizes Maryland's Medicaid program (Maryland Medical Assistance Program) to cover comprehensive obesity treatment, including intensive behavioral therapy, bariatric surgery, and FDA-approved weight management medications, starting January 1, 2027. The bill requires the Maryland Department of Health to notify Medicaid recipients if it chooses to provide this coverage and mandates a report to the legislature by November 1, 2027, on implementation progress. This directly affects Medicaid recipients with obesity by expanding covered treatments beyond current scope. The program may use standard utilization management processes (like for other conditions) to assess medical necessity but is not required to offer the coverage.
